Ingenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients
Hyun Jae Joe, Byung Ho Oh Department of Dermatology, Keimyung University, College of Medicine, Daegu, Republic of Korea Background: Ingenol mebutate (IM), a novel agent for field therapy of actinic keratosis (AK), has a drawback of inducing local skin reactions (LSRs), which may cause discomfort in...
Saved in:
Main Authors: | Joe HJ (Author), Oh BH (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel
by: Berman B
Published: (2012) -
Intense pustular reaction during treatment of actinic keratosis with ingenol mebutate
by: Dorota Jaśkiewicz-Nyckowska, et al.
Published: (2015) -
Ingenol mebutate: A novel topical drug for actinic keratosis
by: Suruchi Aditya, et al.
Published: (2013) -
Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics
by: Campione E, et al.
Published: (2016) -
Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice
by: Skroza N, et al.
Published: (2018)